BOOLIENT, INC. — SEC Form D Filing

BOOLIENT, INC. filed an SEC Form D on July 6, 2026, reporting $2.10M raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
July 6, 2026
Amount reported
$2.10M
Industry
Healthcare Technology
Website
https://boolient.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Healthcare organizations face revenue cycle problems that often require staff to re-investigate issues that have been previously solved by others. This leads to inefficiency, increased costs, and challenges in dealing with denials and underpayments.

Solution

Boolient provides an AI-powered platform that automatically turns knowledge of previously solved revenue cycle problems into a reusable resource. It identifies root causes and solutions for denials and underpayments, helping staff become more productive and allowing organizations to collect cash faster at lower fees.

Why now

The increasing complexity of healthcare billing, coupled with rising operational costs and staffing shortages, makes AI-driven automation for revenue cycle management critically important.

Verdict

Investors backed this round expecting that the clear operational efficiency gains from automating repetitive revenue cycle tasks would unlock rapid adoption, not because the underlying AI held proprietary defensibility. The bet was on selling into an urgent pain point with a clear ROI story, assuming healthcare organizations would prioritize immediate cost savings over longer-term strategic integrations. This limited upside, as the narrative focused on immediate functional improvement rather than large-scale platform disruption or data moats.

Source: SEC EDGAR Form D filing